MCLA-128
MCLA-128-CL01
Phase 2 small_molecule active
Quick answer
MCLA-128 for Solid Tumors is a Phase 2 program (small_molecule) at Partner Therapeutics Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Partner Therapeutics Limited
- Indication
- Solid Tumors
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active